Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
20 January 2025The Fleming Initiative and Google DeepMind lay the path for AI to help tackle antimicrobial resistance
A report by the Fleming Initiative and Google DeepMind suggests that AI can significantly help combat antimicrobial resistance (AMR), a global health threat that is expected to cost nearly 40 million lives by 2050. AI could enable rapid diagnosis, discover new drugs for resistant infections, and predict the spread of resistant bacteria. However, AI systems […]
Read more... -
20 January 2025High-throughput method characterizes hundreds of previously unknown antibiotic resistance mutations
The study presents Quantitative Mutational Scan sequencing (QMS-seq), a high-throughput technique that identifies mutations leading to antimicrobial resistance in a given genomic background and environment. It identifies 812 resistance mutations in four E. coli strains exposed to ciprofloxacin, cycloserine, or nitrofurantoin, revealing that mutations lead to multi-drug and antibiotic-specific resistance, and minor genotypic differences significantly […]
Read more... -
20 January 2025A Comprehensive Review on Exploring the Potential of Phytochemicals and Biogenic Nanoparticles for the Treatment of Antimicrobial-Resistant Pathogenic Bacteria
Antimicrobial resistance (AMR) is a global health concern causing 700,000 deaths annually. Phytochemicals, natural plant constituents, and biogenic nanoparticles are potential alternatives to traditional antibiotics. However, their limited solubility, bioavailability, and stability limit their therapeutic potential. Nanotechnology, particularly biogenic nanoparticles, can overcome these limitations by enhancing biosafety, stability, and controlled release of phytochemical compounds. This […]
Read more...
More news related to Smart innovation